Sano T, Saito T, Kondo M, et al. Enterovirus detection status of patients with herpangina and hand, foot and mouth disease in epidemic season 2007, Kanagawa Prefecture, Japan [J]. Jpn J Infect Dis, 2008,61(2):162-163.
|
Chen KT, Chang HL, Wang ST, et al. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005 [J]. Pediatrics, 2007,120(2):e244-252.
|
Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalence and characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenza like illness in Thailand, 2012 [J]. PLoS One, 2014,9(6):e98888.
|
Chen YH, Lin HC, Lin HC. Increased risk of adverse pregnancy outcomes among women affected by herpangina [J]. Am J Obstet Gynecol, 2010,203(1):49.e1-7.
|
Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71 [J]. Lancet Infect Dis, 2010,10(11):778-790.
|
Shah VA, Chong CY, Chan KP, et al. Clinical characteristics of an outbreak of hand, foot and mouth disease in Singapore [J]. Ann Acad Med Singapore, 2003, 32(3):381-387.
|
Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan [J]. Pediatrics, 2002,109(6):e88.
|
蔡春林,姚相杰,卓菲,等. 深圳地区疱疹性咽峡炎疫情的柯萨奇病毒A4型VP1区基因特征分析 [J]. 中华医学杂志, 2015,95(16):1226-1229.
|
Mirand A, Schuffenecker I, Henquell C, et al. Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries [J]. J Gen Virol, 2010,91(Pt 9):2263-2277.
|
Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens [J]. J Clin Microbiol, 2006,44(8):2698-2704.
|
Yip CC, Lau SK, Woo PC, et al. Recombinant coxsackievirus A2 and deaths of children, Hong Kong, 2012 [J]. Emerg Infect Dis, 2013,19(8):1285-1288.
|
Chen SP, Huang YC, Li WC, et al. Comparison of clinical features between coxsackievirus A2 and enterovirus 71 during the enterovirus outbreak in Taiwan, 2008: a children's hospital experience [J]. J Microbiol Immunol Infect, 2010, 43(2):99-104.
|
李佳萌,李琳,吕莉琨,等. 2014年天津市肠道病毒所致疱疹性咽峡炎临床流行病学分析 [J]. 中华疾病控制杂志, 2016,20(1):26-29.
|
王宏宇,张小爱,许红梅,等. 手足口病患者不同标本中肠道病毒检测结果比较 [J]. 中华疾病控制杂志, 2014,18(6):501-503.
|
Crawford NW, Graham SM. EV71 vaccine: protection from a previously neglected disease [J]. Lancet, 2013,381(9882):1968-1970.
|
Miyazawa I, Azegami Y, Kasuo S, et al. Prevalence of enterovirus from patients with herpangina and hand, foot and mouth disease in Nagano Prefecture, Japan, 2007 [J]. Jpn J Infect Dis, 2008,61(3):247-248.
|
Mirand A, Henquell C, Archimbaud C, et al. Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study [J]. Clin Microbiol Infect, 2012,18(5):E110-E118.
|
El Houmami N, Minodier P, Dubourg G, et al. An outbreak of Kingella kingae infections associated with hand, foot and mouth disease/herpangina virus outbreak in Marseille, France, 2013 [J]. Pediatr Infect Dis J, 2015,34(3):246-250.
|
Yamashita T, Ito M, Taniguchi A, et al. Prevalence of coxsackievirus A5, A6, and A10 in patients with herpangina in Aichi Prefecture, 2005 [J]. Jpn J Infect Dis, 2005,58(6):390-391.
|
Bracho MA, González-Candelas F, Valero A, et al. Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008 [J]. Emerg Infect Dis, 2011,17(12):2223-2231.
|
Huang Y, Zhou Y, Lu H, et al. Characterization of severe hand, foot, and mouth disease in Shenzhen, China, 2009-2013 [J]. J Med Virol, 2015,87(9):1471-1479.
|